Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]
A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Together we Can Turn Type One into Type None JDRF has a Plan to Change the Future JDRF has recently unveiled its plan to turn Type One into Type None. JDRF is the only global organization with a strategic research plan to end T1D. But we need YOU to help us turn this plan into […]
On June 26th JDRF Central PA Chapter staff, board members, families, volunteers, and other supporters gathered at the Penn State Milton Hershey Medical Center for the Chapter’s Annual Meeting. The Central PA Chapter had an amazing year thanks to all of our families, volunteers, donors, and other supporters. But we’ve got a lot more work […]
Leading experts from industry, academia, and government came together the second week of April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas system at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. A commercially-viable artificial pancreas system would mimic the biological […]